Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
基本信息
- 批准号:10612743
- 负责人:
- 金额:$ 411.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAcquired Immunodeficiency SyndromeAffectAgeAgingAncillary StudyAreaArtificial IntelligenceBaltimoreBehavioralBiologicalBiological Specimen BanksCardiovascular DiseasesCardiovascular systemCaringChicagoChronic DiseaseClinicCohort StudiesCryopreservationDataDiabetes MellitusDiseaseDistrict of ColumbiaEchocardiographyEndocrineEnrollmentEpidemicEquilibriumEventFollow-Up StudiesFundingGoalsGrantHIVHIV InfectionsHealthHealth behaviorHomeHospitalsImpaired cognitionInflammationLaboratoriesLeadLeadershipLiver diseasesLong-Term CareLos AngelesLungMachine LearningMalignant NeoplasmsMeasurementMedicineMetabolicMetabolic DiseasesMethodsNational Heart, Lung, and Blood InstituteNatural HistoryNeurocognitiveParticipantPathogenesisPerformancePeripheral Blood Mononuclear CellPersonsPhysical activityPlasmaPlayPolysomnographyPrincipal InvestigatorProductivityProtocols documentationPublicationsQuestionnairesRNAReadingRecording of previous eventsResearchResearch PersonnelRisk FactorsRoleScienceSerumSiteSleepSpecimenT-Lymphocyte SubsetsTechniquesThe Multicenter AIDS Cohort StudyTimeViral load measurementWashingtonWomanWomen&aposs Interagency HIV StudyWorkactigraphyadjudicationantiretroviral therapycareer developmentclinical careclinical research sitecohortcomorbiditydata managementexperiencefollow-uphealth disparityhigh standardimprovedinnovationmenmen who have sex with menneurocognitive disorderpsychosocialrecruitrepositoryresponsesynergism
项目摘要
Project Summary
This application is for the renewal of the Study to Help the AIDS Research Effort (SHARE), which has
been the Baltimore-Washington DC site of the Multicenter AIDS Cohort Study (MACS) since 1984. The MACS
was established with sites in Baltimore-Washington, Chicago, Pittsburgh, and Los Angeles, initially to study the
natural history of HIV infection in men who have sex with men and later, with the advent of effective combination
antiretroviral therapy (cART), the treated history of HIV infection, including the relationship between long-term
controlled HIV infection and chronic diseases and co-morbidities associated with aging. To reflect these
changing priorities in HIV research, SHARE has had subsequent enrollments to balance proportions of HIV- and
HIV+ men and to reflect the HIV epidemic more accurately. Men enrolled have been followed semi annually
since 1984 or enrollment and have a) provided questionnaire data, physical exam data, laboratory data (including
HIV serostatus, T cell subset measurements, and HIV viral load measurements), and a large repository of
plasma, serum, cryopreserved peripheral blood mononuclear cells, and other specimens; and these have
permitted SHARE and MACS to make major contributions to the understanding of treated and untreated HIV
disease, and comorbidities associated with increased survival due to antiretroviral treatment.
The present application, in response to RFA-HL-19-008, aims to extend followup of the SHARE cohort
(about 640 men) from 2019 to 2026, to allow merger of SHARE (and the other MACS sites) with the nine sites
of the Women’s Interagency HIV Study (WIHS) into a single cohort, termed the MACS-WIHS Combined Cohort
Study (CCS), that will include both men and women. The specific aims of the CCS are outlined in a parallel
application from the putative Data and Coordinating Center (DACC) of the CCS, and the 10 Specific Aims of that
single cohort are outlined in the DACC application for the CCS; these include Cardiovascular (CV),
Pulmonary/Sleep (PS), Neurocognitive NC), Aging (AG), Cancer, HIV Pathogenesis (PA), Psychosocial (PS),
Health Disparities, Platform (PL), and Career Development (CD) Aims. The specific aims of the SHARE Clinical
Research Site (CRS) are to: 1) play a leading role in the achievement 7 of these Aims by the CCS (i.e., CV, PS,
AG, PA, PS, PL, and CD), including serving as a reading center for echocardiography and sleep studies; 2) to
contribute to the achievement of the other 3 CCS aims, and 3) to implement all applicable CCS protocols and
support the scientific goals of the CCS. Local initiatives on inflammation and physical activity will also support
these aims, which take full advantage of the extensive follow-up and repository of biological specimens already
available from this cohort and which will be extended under this proposal, enabling further contributions to our
understanding and care of comorbidities and other health issues faced by people living with HIV today.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TODD T BROWN其他文献
TODD T BROWN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TODD T BROWN', 18)}}的其他基金
25th International Workshop on Long-term Complications of HIV and SARS-CoV-2
第 25 届艾滋病毒和 SARS-CoV-2 长期并发症国际研讨会
- 批准号:
10828053 - 财政年份:2023
- 资助金额:
$ 411.09万 - 项目类别:
24th International Workshop on Long-term Complications of HIV and SARS-CoV-2
第 24 届艾滋病毒和 SARS-CoV-2 长期并发症国际研讨会
- 批准号:
10548510 - 财政年份:2022
- 资助金额:
$ 411.09万 - 项目类别:
23rd Annual International Workshop on Co-morbidities and Adverse Drug Reactions in HIV
第23届艾滋病毒合并症和药物不良反应年度国际研讨会
- 批准号:
10327072 - 财政年份:2021
- 资助金额:
$ 411.09万 - 项目类别:
22nd International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV
第22届艾滋病毒合并症和药物不良反应国际研讨会
- 批准号:
10082909 - 财政年份:2020
- 资助金额:
$ 411.09万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10370339 - 财政年份:2019
- 资助金额:
$ 411.09万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10220553 - 财政年份:2019
- 资助金额:
$ 411.09万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10462255 - 财政年份:2019
- 资助金额:
$ 411.09万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10658086 - 财政年份:2019
- 资助金额:
$ 411.09万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10213917 - 财政年份:2019
- 资助金额:
$ 411.09万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
9903475 - 财政年份:2019
- 资助金额:
$ 411.09万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 411.09万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 411.09万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 411.09万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 411.09万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 411.09万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 411.09万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 411.09万 - 项目类别:














{{item.name}}会员




